Description
Seeking adults with moderate to severe non-segmental vitiligo or Alopecia Areata for a study of an investigational drug.
Overview
All participants will be givien one of three different doses of the investigational drug as an IV infusion about once every 4 weeks over a 6-month period.
What we're hoping for
We are studying an investigational drug to find the best dose and see if it is safe and effective in n destroying the cells that cause your non-segmental vitiligo or alopecia areata.
Additional Information
ClinicalTrials.gov Identifier: NCT06602232